This page shows the latest eye disorders news and features for those working in and with pharma, biotech and healthcare.
Other groups are using VR applications to provide motor and cognitive training to stroke and multiple sclerosis patients, treat headache, correct eye disorders such as strabismus and help people cope with
The partners already market Eylea (aflibercept) for use in a number of eye disorders, including wet AMD, and now want to develop a complementary therapy that can be used in combination ... The companies are banking on the two drugs complementing each
The National Institute for Heath and Care Excellence (NICE) today recommended two treatments for eye disorders for use on the NHS in England and Wales. ... Pathological myopia is a chronic form of myopia, which is characterised by excessive lengthening
ReN003 is being assessed as a treatment for rare eye disorder retinitis pigmentosa. ... of inherited eye disorders that affect the retina and can cause severe impairment to vision.
Pathological myopia affects 1 to 3 per cent of the world's population, in some patients leads to the growth of abnormal leaky blood vessels in the back of the eye ... in visual acuity after just two injections into the affected eye.
Fixed-combination licensed to treat glaucoma patients in the US. Novartis subsidiary Alcon has been given a boost after US regulators approved its fixed-combination eye treatment Simbrinza Suspension. ... This pressure is the only modifiable risk factor
More from news
Approximately 5 fully matching, plus 10 partially matching documents found.
Established in 2001, Fishawack Health (FH) is a purposefully built commercialization partner for the biopharmaceutical, medical technology, and wellness industries....